Noller Quoted in Chicago Tribune, Chicago Sun-Times About Alderman’s Cooperation with FBI
13 March 2019
Partner Lisa Noller was quoted in the Chicago Tribune article, “Bombshell filing details FBI’s Two-Year Probe of Alleged Corruption by Ald. Daniel Solis” and the Chicago Sun-Times article, “Ald. Danny Solis Confirms Role as FBI Mole, Pleads for Privacy” about Chicago Ald. Danny Solis’ cooperation with the FBI in an ongoing corruption investigation. The articles revealed parts of previously sealed affidavit used in a search warrant against Solis.
Noller told both newspapers that Solis had decided to cooperate with the federal government to continue to serve the city of Chicago’s best interests. “Because his cooperation is part of an ongoing federal investigation, Mr. Solis cannot comment on the allegations against him contained in the recently unsealed affidavit that is part of the federal investigation.”
For additional coverage, see:
Chicago Tonight
BlockClubChicago
Politico
Noller told both newspapers that Solis had decided to cooperate with the federal government to continue to serve the city of Chicago’s best interests. “Because his cooperation is part of an ongoing federal investigation, Mr. Solis cannot comment on the allegations against him contained in the recently unsealed affidavit that is part of the federal investigation.”
For additional coverage, see:
Chicago Tonight
BlockClubChicago
Politico
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”